Voice of America Episode: Defined Bacterial Consortia for Prevention of CDI Recurrence
Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study
Vedanta Biosciences’ Silvia Caballero, Ph.D., Named as an MIT Technology Review Global Innovator Under 35
Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?